Activation of neutrophil Chemotaxis by leukotriene B₄ and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease

References

• Inflammatory bowel disease, R N Allan, M RB Keighley, J Alexander-Williams, C Hawkins. Churchill Livingstone, London 1983; 156: 361
   Google Scholar
• Saverymuttu S H, Peters A M, Lavender J P, Chad-Wick V S, Hodgson H JF. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease. Gut 1985; 26: 378–83
   PubMed Web of Science ®Google Scholar
• Wandall J H, Binder V. Leukocyte function in Crohn's disease. Gut 1982; 23: 173–80
   PubMed Web of Science ®Google Scholar
• Wandall J H, Binder V. Leukocyte function in ulcerative colitis. Gut 1982; 23: 758–65
   PubMed Web of Science ®Google Scholar
• Morson B C, Dawson I MP. Gastrointestinal Pathology, 1st edn. Blackwell, London 1972; 458–84
   Google Scholar
• Segal A W, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976; 2: 219–21
   PubMed Web of Science ®Google Scholar
• Rhodes J M, Jewel! D P. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis. Gut 1983; 24: 73–7
   PubMed Web of Science ®Google Scholar
• Elmgreen J. Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil Chemotaxis to complement split product C5a. Gut 1984; 25: 737–42
   PubMed Web of Science ®Google Scholar
• Weissmann G, Smolen J E, Korchak H M. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980; 303: 27–34
   PubMed Web of Science ®Google Scholar
• Nielsen O H, Bukhave K, Ahnfelt-Rønne I, Elmgreen J. Arachidonic acid metabolism in human neutrophils. Lack of effect of cyclosporine A. Int J Immunopharmacol 1986; 8: 419–26
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Pickett W C. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B4. J Exp Med 1981; 153: 482–7
   PubMed Web of Science ®Google Scholar
• Shak S, Goldstein I M. Leukotriene B4 ω-hydroxylase in human polymorphonuclear leukocytes. J Clin Invest 1985; 76: 1218–28
   PubMed Web of Science ®Google Scholar
• Shak S, Reich N O, Goldstein I M, Oritz de Montellano P R. Leukotriene B4 ω-hydroxylase in human polymorphonuclear leukocytes. J Biol Chem 1985; 260: 13023–8
   PubMed Web of Science ®Google Scholar
• O'Flaherty J T, Hammett M J, Shewmake T B, Wykl R L, Love S H, McCall C E, Thomas M J. Evidence of 5,12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation. Biochem Biophys Res Commun 1981; 103: 552–8
   PubMed Web of Science ®Google Scholar
• Nagy L, Lee T H, Goetzl E J, Pickett W C, Kay A B. Complement receptor enhancement and Chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol 1982; 47: 541–7
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Brindley L L, Goldmann D W. Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow reacting substance of anaphylaxis. Immunology 1983; 50: 35–41
   PubMed Web of Science ®Google Scholar
• Borgeat P, Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes. Effects of ionophore A23187. Proc Natl Acad Sci 1979; 76: 2148–52
   PubMed Web of Science ®Google Scholar
• Williams L T, Snyderman R, Pike M C, Lefkowitz R J. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci 1977; 74: 1204–8
   PubMed Web of Science ®Google Scholar
• Chenoweth D E, Hugli T E. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci 1978; 75: 3943–8
   PubMed Web of Science ®Google Scholar
• Goldman D W, Goetzl E J. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. J Exp Med 1984; 159: 1027–41
   PubMed Web of Science ®Google Scholar
• Kreisle R A, Parker C W. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol 1982; 129: 1600–4
   PubMed Web of Science ®Google Scholar
• Binder V, Both H, Hansen P K, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962–1978. Gastroenterology 1982; 83: 563–8
   PubMed Web of Science ®Google Scholar
• Tvede M, Bondesen S, Nielsen O H, Rasmussen S N. Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol 1983; 18: 783–9
   PubMed Web of Science ®Google Scholar
• Zigmond S H, Hirsch J G. Leucocyte locomotion and Chemotaxis. J Exp Med 1973; 137: 387–411
   PubMed Web of Science ®Google Scholar
• Wilkinson P C. Chemotaxis and Inflammation. Churchill Livingstone, Edingburgh 1974
   Google Scholar
• Hodgson H JF, Potter B J, Jewell D P. C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1977; 28: 490–5
   PubMed Web of Science ®Google Scholar
• Potter B J, Brown D JC, Watson A, Jewell D P. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease. Gut 1980; 21: 1030–4
   PubMed Web of Science ®Google Scholar
• Boughton-Smith N K, Hawkey C J, Whittle BJR. Biosynthesis of lipoxygenase and cyclo-oxygenase products for 14C-arachidonic acid by human colonic mucosa. Gut 1983; 24: 1176–82
   PubMed Web of Science ®Google Scholar
• Elmgreen J, Berkowicz A, Sørensen H. Hypercatabolism of complement in Crohn's disease. Assessment of circulating C3c. Acta Med Scand 1983; 214: 403–7
   PubMedGoogle Scholar
• Sharon P, Stenson W F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453–60
   PubMed Web of Science ®Google Scholar
• Nielsen O H, Ahnfelt-Rønne I, Elmgreen J. Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease. Enhanced release of leukotriene B4 from activated neutrophils. Gut 1987; 28: 181–5
   PubMed Web of Science ®Google Scholar
• Flower R J, Blackwell G J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin synthesis. Nature 1979; 248: 456–9
   Web of Science ®Google Scholar
• Nielsen O H, Bukhave K, Elmgreen J, Ahnfelt-Rønne I. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci, (in press)
   Web of Science ®Google Scholar
• Goldman D W, Koo C H, Gifford L A, Marotti T, Chernov-Rogan T, Goetzl E J (1986) Regulation of the affinity and cellular presentation of human leukocyte receptors for leukotriene B4. Proceedings of the 6th International Conference on Prostaglandins and Related Compounds, Florence, June, 1986. Raven Press, New York
   Google Scholar
• Dahinden C A, Clancy R M, Hugli T E. Stereospecificity of leukotriene B4 and structure-function relationships for Chemotaxis of human neutrophils. J Immunol 1984; 133: 1477–82
   PubMed Web of Science ®Google Scholar
• Czarnetzki B M, Rosenbach T. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-oxidation products in vitro. Prostaglandins 1986; 31: 851–8
   PubMed Web of Science ®Google Scholar
• Hansson G, Lindgren A J, Dahlén S-E, Hedqvist P, Samuelsson B. Identification and biologic activity of novel-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett 1981; 130: 107–10
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Pickett W C. The human PMN leukocyte chemotactic activity of complex hydroxyeicosatetraenoic acids (HETEs). J Immunol 1980; 125: 1789–91
   PubMed Web of Science ®Google Scholar
• Palmblad J, Malmsten C L, Udén A-M, Rådmark O, Engstedt L, Samuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil Chemotaxis and adherence. Blood 1981; 58: 658–61
   PubMed Web of Science ®Google Scholar